Miltefosine treatment for kala azar is to be given for:
**Core Concept**
Miltefosine is an oral antiprotozoal medication used for the treatment of visceral leishmaniasis, also known as kala azar. The drug works by interfering with the parasite's cell membrane function and inducing apoptosis.
**Why the Correct Answer is Right**
Miltefosine is specifically indicated for the treatment of visceral leishmaniasis, particularly in India. The recommended duration of treatment with miltefosine is 28 days. This duration is crucial for achieving a sustained clinical response and reducing the risk of relapse. The drug has been shown to be effective in patients with both new and previously treated cases of kala azar.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as the duration of treatment with miltefosine is not 21 days.
**Option B:** This option is incorrect as the duration of treatment with miltefosine is not 14 days.
**Option C:** This option is incorrect as the duration of treatment with miltefosine is not 35 days.
**Clinical Pearl / High-Yield Fact**
It is essential to note that miltefosine is not recommended for use in pregnant or breastfeeding women due to potential teratogenic effects and toxicity to the fetus.
**Correct Answer:** D. 28 days.